A phase I study of panobinostat and ruxolitinib in patients...

  • Main
  • 2019 / 11
  • A phase I study of panobinostat and ruxolitinib in patients...
Leukemia Research 2019 / 11

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-­polycythemia vera/essential thrombocythemia myelofibrosis (post-­PV/ET MF)

Mascarenhas, J., Marcellino, B.K., Lu, M., Kremyanskaya, M., Fabris, F., Sandy, L., Mehrotra, M., Houldsworth, J., Najfeld, V., El Jamal, S., Petersen, B., Moshier, E., Hoffman, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/j.leukres.2019.106272
Date:
November, 2019
File:
PDF, 2.66 MB
english, 2019
Conversion to is in progress
Conversion to is failed